{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:20:54Z","timestamp":1791174054380,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2010,8,1]],"date-time":"2010-08-01T00:00:00Z","timestamp":1280620800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1016\/j.expneurol.2010.03.028","type":"journal-article","created":{"date-parts":[[2010,4,2]],"date-time":"2010-04-02T08:25:09Z","timestamp":1270196709000},"page":"331-335","source":"Crossref","is-referenced-by-count":115,"title":["Complex I: Inhibitors, inhibition and neurodegeneration"],"prefix":"10.1016","volume":"224","author":[{"given":"A.H.V.","family":"Schapira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2010.03.028_bib1","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1046\/j.1471-4159.2000.740878.x","article-title":"Frontal lobe dysfunction in progressive supranuclear palsy: evidence for oxidative stress and mitochondrial impairment","volume":"74","author":"Albers","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.03.028_bib2","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/ng1769","article-title":"High levels of mitochondrial DNA deletions in substantia nigra neurons in aging and Parkinson disease","volume":"38","author":"Bender","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2010.03.028_bib3","doi-asserted-by":"crossref","first-page":"29773","DOI":"10.1074\/jbc.M109.032144","article-title":"Structural basis for the mechanism of respiratory complex I","volume":"284","author":"Berrisford","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2010.03.028_bib4","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.028_bib5","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/hmg\/9.2.275","article-title":"Clinical, biochemical and molecular genetic correlations in Friedreich's ataxia","volume":"9","author":"Bradley","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.expneurol.2010.03.028_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0140-6736(98)10166-6","article-title":"Possible relation of atypical parkinsonism in the French West Indies with consumption of tropical plants: a case-control study. Caribbean Parkinsonism Study Group","volume":"354","author":"Caparros-Lefebvre","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2010.03.028_bib7","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/brain\/awf086","article-title":"Guadeloupean parkinsonism: a cluster of progressive supranuclear palsy-like tauopathy","volume":"125","author":"Caparros-Lefebvre","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2010.03.028_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1471-4159.2003.02138.x","article-title":"Annonacin, a lipophilic inhibitor of mitochondrial complex I, induces nigral and striatal neurodegeneration in rats: possible relevance for atypical parkinsonism in Guadeloupe","volume":"88","author":"Champy","year":"2004","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.03.028_bib9","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/j.1471-4159.1992.tb09789.x","article-title":"Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement","volume":"58","author":"Cleeter","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.03.028_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/ana.410440208","article-title":"The influence of nuclear background on the biochemical expression of 3460 Leber's hereditary optic neuropathy","volume":"44","author":"Cock","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib11","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0022-510X(92)90270-U","article-title":"Analyses of mitochondrial respiratory chain function and mitochondrial DNA deletion in human skeletal muscle: effect of ageing","volume":"113","author":"Cooper","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2010.03.028_bib12","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/mds.870100311","article-title":"l-dihydroxyphenylalanine and complex I deficiency in Parkinson's disease brain","volume":"10","author":"Cooper","year":"1995","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2010.03.028_bib13","doi-asserted-by":"crossref","first-page":"23802","DOI":"10.1074\/jbc.M500356200","article-title":"Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice","volume":"280","author":"David","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2010.03.028_bib14","article-title":"Transport of proteins across or into the mitochondrial outer membrane","author":"Endo","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2010.03.028_bib15","doi-asserted-by":"crossref","first-page":"7827","DOI":"10.1523\/JNEUROSCI.1644-07.2007","article-title":"Annonacin, a natural mitochondrial complex I inhibitor, causes tau pathology in cultured neurons","volume":"27","author":"Escobar-Khondiker","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.028_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1749-6632.2000.tb06907.x","article-title":"Tau gene mutations in frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17). Their relevance for understanding the neurogenerative process","volume":"920","author":"Goedert","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2010.03.028_bib17","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1212\/WNL.47.1.148","article-title":"Follow-up study of risk factors in progressive supranuclear palsy","volume":"47","author":"Golbe","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2010.03.028_bib18","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/ana.410390317","article-title":"Mitochondrial defect in Huntington's disease caudate nucleus","volume":"39","author":"Gu","year":"1996","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib19","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/ana.410370604","article-title":"Low platelet mitochondrial complex I and complex II\/III activity in early untreated Parkinson's disease","volume":"37","author":"Haas","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib20","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.expneurol.2009.08.004","article-title":"Natural lipophilic inhibitors of mitochondrial complex I are candidate toxins for sporadic neurodegenerative tau pathologies","volume":"220","author":"Hollerhage","year":"2009","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib21","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/WNL.56.12.1702","article-title":"Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype","volume":"56","author":"Houlden","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2010.03.028_bib22","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1212\/WNL.43.12.2689","article-title":"Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy","volume":"43","author":"Jenkins","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2010.03.028_bib23","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/ng1778","article-title":"Mitochondrial DNA deletions are abundant and cause functional impairment in aged human substantia nigra neurons","volume":"38","author":"Kraytsberg","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.expneurol.2010.03.028_bib24","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1002\/ana.410320612","article-title":"Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group","volume":"32","author":"Krige","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib25","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2010.03.028_bib26","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0306-4522(03)00441-X","article-title":"The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism","volume":"121","author":"Lannuzel","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2010.03.028_bib27","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1093\/brain\/awl347","article-title":"Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?","volume":"130","author":"Lannuzel","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2010.03.028_bib28","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0140-6736(99)05225-3","article-title":"Mitochondrial respiratory chain disorders I: mitochondrial DNA defects","volume":"355","author":"Leonard","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2010.03.028_bib29","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(99)05226-5","article-title":"Mitochondrial respiratory chain disorders II: neurodegenerative disorders and nuclear gene defects","volume":"355","author":"Leonard","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2010.03.028_bib30","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/nn.2349","article-title":"Mutant LRRK2(R1441G) BAC transgenic mice recapitulate cardinal features of Parkinson's disease","volume":"12","author":"Li","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.028_bib31","doi-asserted-by":"crossref","first-page":"11492","DOI":"10.1073\/pnas.96.20.11492","article-title":"Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia","volume":"96","author":"Lodi","year":"1999","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"10.1016\/j.expneurol.2010.03.028_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/1531-8249(200007)48:1<72::AID-ANA11>3.0.CO;2-I","article-title":"Abnormal in vivo skeletal muscle energy metabolism in Huntington's disease and dentatorubropallidoluysian atrophy","volume":"48","author":"Lodi","year":"2000","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib33","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1212\/01.wnl.0000276955.23735.eb","article-title":"Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease","volume":"69","author":"Luoma","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2010.03.028_bib34","article-title":"Control of mitochondrial transport and localization in neurons","author":"Macaskill","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib35","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/156720508785908946","article-title":"Mitochondria, mitochondrial DNA and Alzheimer's disease. What comes first?","volume":"5","author":"Mancuso","year":"2008","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.expneurol.2010.03.028_bib36","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/0140-6736(90)92242-A","article-title":"Mitochondrial function and parental sex effect in Huntington's disease","volume":"336","author":"Mann","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2010.03.028_bib37","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/ana.410360612","article-title":"Complex I, iron, and ferritin in Parkinson's disease substantia nigra","volume":"36","author":"Mann","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00769638","article-title":"Molecular defects of NADH-ubiquinone oxidoreductase (complex I) in mitochondrial diseases","volume":"20","author":"Morgan-Hughes","year":"1988","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.expneurol.2010.03.028_bib39","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0925-4439(95)00020-5","article-title":"Mitochondrial DNA (mtDNA) diseases: correlation of genotype to phenotype","volume":"1271","author":"Morgan-Hughes","year":"1995","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2010.03.028_bib40","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0168-8278(98)80278-X","article-title":"Liver failure associated with mitochondrial DNA depletion","volume":"28","author":"Morris","year":"1998","journal-title":"J. Hepatol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/jnnp.66.5.665","article-title":"The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases","volume":"66","author":"Morris","year":"1999","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.028_bib42","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/0024-3205(85)90146-8","article-title":"Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1, 2, 5, 6-tetrahydropyridine","volume":"36","author":"Nicklas","year":"1985","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2010.03.028_bib43","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib44","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0005-2728(98)00032-2","article-title":"Human complex I defects in neurodegenerative diseases","volume":"1364","author":"Schapira","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.expneurol.2010.03.028_bib45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(06)68970-8","article-title":"Mitochondrial disease","volume":"368","author":"Schapira","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2010.03.028_bib46","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S1474-4422(07)70327-7","article-title":"Mitochondria in the aetiology and pathogenesis of Parkinson's disease","volume":"7","author":"Schapira","year":"2008","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib47","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(88)91296-2","article-title":"Molecular basis of mitochondrial myopathies: polypeptide analysis in complex-I deficiency","volume":"1","author":"Schapira","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2010.03.028_bib48","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(89)92366-0","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"1","author":"Schapira","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2010.03.028_bib49","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.03.028_bib50","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1111\/j.1471-4159.1990.tb05809.x","article-title":"Anatomic and disease specificity of NADH CoQ1 reductase (complex I) deficiency in Parkinson's disease","volume":"55","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.03.028_bib51","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/qjmed\/86.10.657","article-title":"Smoking and mitochondrial function: a model for environmental toxins","volume":"86","author":"Smith","year":"1993","journal-title":"Q.J. Med."},{"key":"10.1016\/j.expneurol.2010.03.028_bib52","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0022-510X(94)90055-8","article-title":"Platelet mitochondrial function in Leber's hereditary optic neuropathy","volume":"122","author":"Smith","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2010.03.028_bib53","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1002\/mds.22023","article-title":"Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial","volume":"23","author":"Stamelou","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.expneurol.2010.03.028_bib54","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/jcbfm.2009.2","article-title":"In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy","volume":"29","author":"Stamelou","year":"2009","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.expneurol.2010.03.028_bib55","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1471-4159.2009.06316.x","article-title":"Differential effect of three-repeat and four-repeat tau on mitochondrial axonal transport","volume":"111","author":"Stoothoff","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2010.03.028_bib56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neulet.2004.11.023","article-title":"Analysis of the trinucleotide CAG repeat from the DNA polymerase gamma gene (POLG) in patients with Parkinson's disease","volume":"376","author":"Taanman","year":"2005","journal-title":"Neurosci. Lett."},{"issue":"Pt 3","key":"10.1016\/j.expneurol.2010.03.028_bib57","first-page":"451","article-title":"Myopathy in vitamin E deficient rats: muscle fibre necrosis associated with disturbances of mitochondrial function","volume":"183","author":"Thomas","year":"1993","journal-title":"J. Anat."},{"key":"10.1016\/j.expneurol.2010.03.028_bib58","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/nn0905-1136","article-title":"Pathological tau: a loss of normal function or a gain in toxicity?","volume":"8","author":"Trojanowski","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2010.03.028_bib59","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1136\/jnnp.2008.149849","article-title":"Risk factors for progressive supranuclear palsy: a case-control study in France","volume":"80","author":"Vidal","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.expneurol.2010.03.028_bib60","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.410360513","article-title":"Positron emission tomographic evidence for progression of human MPTP-induced dopaminergic lesions","volume":"36","author":"Vingerhoets","year":"1994","journal-title":"Ann. Neurol."},{"issue":"Suppl 3","key":"10.1016\/j.expneurol.2010.03.028_bib61","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1002\/ana.10487","article-title":"Genetic and environmental factors in the cause of Parkinson's disease","volume":"53","author":"Warner","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2010.03.028_bib62","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1021\/bi027158b","article-title":"The proton-translocating NADH-quinone oxidoreductase in the respiratory chain: the secret unlocked","volume":"42","author":"Yagi","year":"2003","journal-title":"Biochemistry"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610001147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488610001147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,12]],"date-time":"2018-12-12T04:25:57Z","timestamp":1544588757000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488610001147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["S0014488610001147"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2010.03.028","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2010,8]]}}}